2026 Canadian Hemoglobinopathy Association Annual Conference and AGM

The 2026 CanHaem Annual Conference

The 2026 CanHaem Annual Conference will be taking place Friday, September 25th and Saturday, September 26th in Banff, AB.

The official hotel and venue for the 2026 CanHaem Annual Conference is Banff Centre for Arts and Creativity, 107 Tunnel Mountain Dr, Banff, AB T1L 1H5.

**IMPORTANT** If your booking will include extra nights on either end of the conference block, please first click “check availability”, then click “Edit Stay Details”, click the dates you want, click done, click “update stay details” and select your room type.

Follow the link: Book your group rate for 2026 CanHaem Annual Conference

Air Travel Air Canada is the preferred airline for the 2026 CanHaem Annual Meeting, which will be held Friday, September 25, 2026, to Saturday, September 26, 2026.

This a promotion code for the convention product. To book a flight with your promotion code, access aircanada.com and enter your promotion code COMING SOON in the Promotion Code Box.

The goal of the scientific session at the CanHaem annual meeting is to present novel Canadian research in the field of hemoglobinopathies.

Call for Abstracts!

All abstract submissions must be submitted by Thursday, June 18, 2026
Please not the early deadline!

Eligibility criteria:

  • All health care providers are invited to submit their research in the field of hemoglobinopathies.
  • At least one of the authors must be a CanHaem member.
  • If none of the abstract authors is a CanHaem member, the abstract must be sponsored by a current CanHaem member.
  • Abstracts with a presenting author who is (a) an employee of publicly traded or privately held ineligible companies, or (b) owner of a privately held company, will not be considered for oral presentation.
  • Ineligible companies are those whose primary business is producing, marketing, re-selling, or distributing healthcare products used by or on patients. Examples of such companies can be found on the ACCME website.

Maximum word length: 350 words.

Abstracts will be selected by a scientific committee and judged on the clarity of the presentation, quality of the work, state of completion, novelty, and relevance to the field of hemoglobinopathies.